POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	1elk	TARGET OF MYB1 (Homo sapiens)	4 / 6	LEU A  74 GLU A  75 LYS A 116 LEU A 120	None	0.80A	12.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	1m7k	SILENCER OF DEATH DOMAINS (Homo sapiens)	4 / 6	GLN A 391 LEU A 393 GLU A 394 LYS A 444	None	0.87A	15.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	1ujj	ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA1 (Homo sapiens)	4 / 6	LEU A  70 GLU A  71 LYS A 114 LEU A 118	None	0.86A	14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	1zvd	SMAD UBIQUITINATION REGULATORY FACTOR 2 (Homo sapiens)	4 / 6	GLN A 385 LEU A 383 GLU A 382 LEU A 613	None	0.69A	6.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	2fcw	ALPHA-2-MACROGLOBULI N RECEPTOR-ASSOCIATED PROTEIN (Homo sapiens)	4 / 6	LYS A 289 LEU A 293 GLU A 294 LEU A 264	None	0.94A	16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	2q8h	[PYRUVATE DEHYDROGENASE [LIPOAMIDE]] KINASE ISOZYME 1 (Homo sapiens)	4 / 6	GLN A  81 LEU A  79 GLU A  82 LEU A 194	None	0.93A	7.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	2w4o	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE TYPE IV (Homo sapiens)	4 / 6	GLN A 147 LEU A 149 GLU A 150 LEU A 295	None	0.93A	7.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	2xss	CGMP-SPECIFIC 3', 5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 6	GLN A 490 LEU A 492 GLU A 489 LEU A 452	None	0.75A	11.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	3bhh	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE TYPE II BETA CHAIN (Homo sapiens)	4 / 6	GLN A 119 LEU A 121 GLU A 122 LEU A 267	None	0.78A	7.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	4 / 6	GLN A 124 LEU A 126 GLU A 127 LEU A 271	None	0.87A	7.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	3e0j	DNA POLYMERASE SUBUNIT DELTA-2 (Homo sapiens)	4 / 6	LEU A 365 GLU A 366 LYS A 413 LEU A 425	None	0.71A	4.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	3lfv	CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 6	GLN A 490 LEU A 492 GLU A 489 LEU A 452	None	0.77A	6.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	3lm5	SERINE/THREONINE-PRO TEIN KINASE 17B (Homo sapiens)	4 / 6	GLN A 141 LEU A 143 GLU A 144 LEU A 288	None	0.85A	6.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	3qj4	RENALASE (Homo sapiens)	4 / 6	GLN A 183 LEU A 185 GLU A 186 LEU A 167	None	0.84A	6.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	3rwr	DNA REPAIR PROTEIN XRCC4 (Homo sapiens)	4 / 6	LEU A  70 GLU A  69 LYS A  99 LEU A 108	None	0.91A	12.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	4bc6	SERINE/THREONINE-PRO TEIN KINASE 10 (Homo sapiens)	4 / 6	GLN A 140 LEU A 142 GLU A 143 LEU A 289	None	0.84A	8.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	4c7n	MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR SYNTHETIC ALPHA-HELIX, IM10 (Homo sapiens; synthetic construct)	4 / 6	GLN A  39 LEU A  41 GLU A  42 LEU B  42	None	0.80A	26.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	4c7n	MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR SYNTHETIC ALPHA-HELIX, IM10 (Homo sapiens; synthetic construct)	4 / 6	GLN B  40 LEU B  42 GLU B  43 LEU A  41	None	0.69A	22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	4c9b	PRE-MRNA-SPLICING FACTOR CWC22 HOMOLOG (Homo sapiens)	4 / 6	GLN B 187 LEU B 185 GLU B 184 LEU B 169	None	0.85A	9.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	4fys	AMINOPEPTIDASE N (Homo sapiens)	4 / 6	GLN A 916 LEU A 918 GLU A 919 LEU A 941	None	0.90A	2.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	4zk3	SERPIN B3 (Homo sapiens)	4 / 6	GLN A 255 LEU A 257 GLU A 258 LEU A 370	None	0.92A	6.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	4zry	KERATIN, TYPE I CYTOSKELETAL 10 KERATIN, TYPE II CYTOSKELETAL 1 (Homo sapiens; Homo sapiens)	4 / 6	GLN A 387 LEU A 389 GLU A 390 LEU B 422	None	0.86A	16.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	5j4o	SPECTRIN ALPHA CHAIN, ERYTHROCYTIC 1 (Homo sapiens)	4 / 6	LYS A  50 GLN A  52 LEU A  54 GLU A  55	None	0.88A	9.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	5nug	CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1 (Homo sapiens)	4 / 6	LYS A3225 GLN A3227 LEU A3229 GLU A3230	None	0.87A	0.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	5v8w	INTEGRATOR COMPLEX SUBUNIT 9 INTEGRATOR COMPLEX SUBUNIT 11 (Homo sapiens; Homo sapiens)	4 / 6	GLN B 497 LEU B 499 GLU B 496 LEU A 584	None	0.82A	17.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	5vil	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5 (Homo sapiens)	4 / 6	GLN A 786 LEU A 788 GLU A 789 LEU A 933	None	0.76A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_A_LEIA16_0 (COIL SER L16D-PEN)	5whr	INDOLEAMINE 2,3-DIOXYGENASE 1 (Homo sapiens)	4 / 6	LYS A  74 GLN A  76 LEU A  78 LEU A  32	None	0.64A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	1evs	ONCOSTATIN M (Homo sapiens)	4 / 5	LEU A  85 GLN A  90 LEU A  88 GLU A  89	None	1.08A	11.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	1gjj	LAP2 (Homo sapiens)	4 / 5	LEU A  40 GLN A  32 LEU A  27 GLU A  31	None	0.89A	12.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	1wdz	INSULIN RECEPTOR SUBSTRATE P53 (Homo sapiens)	4 / 5	LEU A 102 GLN A 107 LEU A 105 GLU A 106	None	1.10A	10.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	2c11	MEMBRANE COPPER AMINE OXIDASE (Homo sapiens)	4 / 5	LEU A 194 GLN A 190 LEU A 277 GLU A 278	None	1.12A	3.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	2dh3	4F2 CELL-SURFACE ANTIGEN HEAVY CHAIN (Homo sapiens)	4 / 5	LEU A 510 GLN A 478 LEU A 488 GLU A 511	None	1.15A	6.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	2lp0	HOMEOBOX PROTEIN HOX-C9 (Homo sapiens)	4 / 5	LYS A  26 GLN A  28 LEU A  30 GLU A  31	None	0.99A	13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	2rsv	SERINE/THREONINE-PRO TEIN KINASE VRK1 (Homo sapiens)	4 / 5	LEU A 155 GLN A 326 LEU A 324 GLU A 298	None	1.12A	6.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	2ve7	KINETOCHORE PROTEIN HEC1, KINETOCHORE PROTEIN SPC25 KINETOCHORE PROTEIN NUF2, KINETOCHORE PROTEIN SPC24 (Homo sapiens; Homo sapiens)	4 / 5	LEU C 155 LYS A 264 LEU A 268 GLU A 269	None	1.14A	9.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	2xio	PUTATIVE DEOXYRIBONUCLEASE TATDN1 (Homo sapiens)	4 / 5	LEU A  93 GLN A 141 LEU A 138 GLU A 137	None	1.12A	7.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	3bhh	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE TYPE II BETA CHAIN (Homo sapiens)	4 / 5	LEU A 267 GLN A 119 LEU A 121 GLU A 122	None	1.08A	7.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	4 / 5	LEU A 502 LYS A 538 LEU A 534 GLU A 533	None	1.16A	3.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	3fht	ATP-DEPENDENT RNA HELICASE DDX19B (Homo sapiens)	4 / 5	LEU A 353 LYS A 320 GLN A 322 LEU A 324	None	1.14A	6.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	4 / 5	LEU A 104 LYS A  76 LEU A  72 GLU A  71	NIL  A   1 ( 4.3A) None None NIL  A   1 (-3.7A)	1.12A	7.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	3lhr	ZINC FINGER PROTEIN 24 (Homo sapiens)	4 / 5	LYS A  45 GLN A  47 LEU A  49 GLU A  50	None None EMC  A  97 (-3.5A) EMC  A  97 (-4.0A)	0.90A	17.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	3mpx	FYVE, RHOGEF AND PH DOMAIN-CONTAINING PROTEIN 5 (Homo sapiens)	4 / 5	LEU A1003 GLN A 944 LEU A 942 GLU A 941	None	1.10A	6.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	3soa	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE TYPE II SUBUNIT ALPHA WITH A BETA 7 LINKER (Homo sapiens)	4 / 5	LEU A 266 GLN A 118 LEU A 120 GLU A 121	None	1.03A	5.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	4bc6	SERINE/THREONINE-PRO TEIN KINASE 10 (Homo sapiens)	4 / 5	LEU A 289 GLN A 140 LEU A 142 GLU A 143	None	1.09A	8.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	4ki9	DUAL SPECIFICITY PROTEIN PHOSPHATASE 12 (Homo sapiens)	4 / 5	LEU A  28 LYS A 144 GLN A 146 LEU A 148	None	0.90A	11.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	4piv	FATTY ACID SYNTHASE (Homo sapiens)	4 / 5	LEU A2056 LYS A1116 GLN A2059 LEU A2106	None SO4  A2203 ( 4.8A) None None	1.07A	3.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	4qgk	FATTY ALDEHYDE DEHYDROGENASE (Homo sapiens)	4 / 5	LEU A  72 GLN A  25 LEU A  27 GLU A  28	None	1.00A	5.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	6ao5	SERINE/THREONINE-PRO TEIN KINASE 3 PROTEIN SALVADOR HOMOLOG 1 (Homo sapiens; Homo sapiens)	4 / 5	LEU A 466 GLN B 349 LEU B 347 GLU B 346	None	0.68A	6.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	6b4j	NUCLEOPORIN LIKE 2 (Homo sapiens)	4 / 5	LEU C 393 GLN C 400 LEU C 398 GLU C 397	None	1.15A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	1yvl	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1-ALPHA/BETA (Homo sapiens)	4 / 6	LYS A 298 GLN A 285 LEU A 283 GLU A 284	None	1.12A	7.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	2p28	INTEGRIN BETA-2 INTEGRIN BETA-2 (Homo sapiens; Homo sapiens)	4 / 6	LEU A  62 GLN B 418 LEU A  83 GLU A  64	None	1.07A	14.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	2ve7	KINETOCHORE PROTEIN HEC1, KINETOCHORE PROTEIN SPC25 KINETOCHORE PROTEIN NUF2, KINETOCHORE PROTEIN SPC24 (Homo sapiens; Homo sapiens)	5 / 6	LYS C 151 LEU C 155 LYS A 264 LEU A 268 GLU A 269	None	1.35A	9.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	3lhr	ZINC FINGER PROTEIN 24 (Homo sapiens)	4 / 6	LYS A  45 GLN A  47 LEU A  49 GLU A  50	None None EMC  A  97 (-3.5A) EMC  A  97 (-4.0A)	1.09A	17.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	3ngo	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 6-LIKE (Homo sapiens)	4 / 6	LYS A 178 LEU A 501 LEU A 536 GLU A 537	None	0.83A	8.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	3u21	NUCLEAR FACTOR RELATED TO KAPPA-B-BINDING PROTEIN (Homo sapiens)	4 / 6	LEU A 461 GLN A 392 LEU A 460 GLU A 450	None MLY  A 459 ( 3.8A) MLY  A 459 ( 4.2A) MLY  A 452 ( 3.4A)	1.06A	14.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	4l6y	PROTEIN REGULATOR OF CYTOKINESIS 1 (Homo sapiens)	4 / 6	LEU A 124 GLN A 119 LEU A 121 GLU A 120	None	1.05A	6.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	4ov6	PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (Homo sapiens)	4 / 6	LEU B 406 GLN B 413 LEU B 411 GLU B 410	None PG4  B 503 (-3.5A) None None	1.13A	6.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	4z07	CGMP-DEPENDENT PROTEIN KINASE 1 (Homo sapiens)	4 / 6	LYS A 197 LYS A 167 LEU A 172 GLU A 164	None PCG  A 401 ( 4.5A) PCG  A 401 (-3.9A) None	1.13A	8.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	4zmx	CADHERIN-3 (Homo sapiens)	4 / 6	LEU A  61 GLN A  23 LEU A  60 GLU A  54	None	0.84A	10.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	4zry	KERATIN, TYPE I CYTOSKELETAL 10 KERATIN, TYPE II CYTOSKELETAL 1 (Homo sapiens; Homo sapiens)	4 / 6	LEU B 422 GLN A 387 LEU A 389 GLU A 390	None	1.02A	15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	5dzz	DESMOPLAKIN (Homo sapiens)	4 / 6	LYS A1999 LEU A1994 LYS A1988 LEU A1991	None	1.12A	5.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	5grn	PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA (Homo sapiens)	4 / 6	LEU A 839 GLN A 639 LEU A 641 GLU A 637	None	1.04A	6.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	5gtm	INTERFERON-INDUCED GTP-BINDING PROTEIN MX1 (Homo sapiens)	4 / 6	LEU A  70 GLN A  66 LEU A  68 GLU A  65	None	1.05A	5.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	5jyl	CADHERIN-3 (Homo sapiens)	4 / 6	LEU A  61 GLN A  23 LEU A  60 GLU A  54	None	0.88A	19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	5l3d	LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A (Homo sapiens)	4 / 6	LYS A 507 GLN A 509 LEU A 511 GLU A 512	None	0.82A	3.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	5lp8	E3 UBIQUITIN-PROTEIN LIGASE HUWE1 (Homo sapiens)	4 / 6	LEU B4008 GLN B4003 LEU B4005 GLU B4004	None	1.10A	5.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	5mgt	KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY B MEMBER 1 (Homo sapiens)	4 / 6	LEU C 144 LYS C 104 GLN C 100 LEU C 106	None	0.87A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_C_LEIC16_0 (COIL SER L16D-PEN)	6b4j	NUCLEOPORIN LIKE 2 (Homo sapiens)	4 / 6	LEU C 393 GLN C 400 LEU C 398 GLU C 397	None	1.01A	undetectable